Capital Research Global Investors cut its stake in Masimo Corporation (NASDAQ:MASI – Free Report) by 65.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 637,894 shares of the medical equipment provider’s stock after selling 1,216,234 shares during the quarter. Capital Research Global Investors’ holdings in Masimo were worth $82,964,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Vanguard Group Inc. raised its holdings in Masimo by 3.7% in the 3rd quarter. Vanguard Group Inc. now owns 4,810,011 shares of the medical equipment provider’s stock valued at $709,717,000 after acquiring an additional 171,876 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Masimo by 1.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 2,663,875 shares of the medical equipment provider’s stock valued at $346,464,000 after acquiring an additional 43,915 shares in the last quarter. Westfield Capital Management Co. LP raised its holdings in Masimo by 7.2% in the 4th quarter. Westfield Capital Management Co. LP now owns 1,522,049 shares of the medical equipment provider’s stock valued at $197,958,000 after acquiring an additional 102,799 shares in the last quarter. State Street Corp raised its holdings in Masimo by 0.7% in the 2nd quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock valued at $250,041,000 after acquiring an additional 10,403 shares in the last quarter. Finally, Alyeska Investment Group L.P. raised its holdings in Masimo by 21.7% in the 3rd quarter. Alyeska Investment Group L.P. now owns 1,381,085 shares of the medical equipment provider’s stock valued at $203,779,000 after acquiring an additional 246,595 shares in the last quarter. 85.96% of the stock is owned by institutional investors and hedge funds.
Masimo Trading Up 0.6%
Shares of MASI opened at $179.94 on Tuesday. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $179.97. The business’s fifty day moving average is $178.51 and its 200-day moving average is $159.66. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68. The firm has a market cap of $9.42 billion, a price-to-earnings ratio of -17.07, a PEG ratio of 1.81 and a beta of 1.11.
Analyst Upgrades and Downgrades
Check Out Our Latest Research Report on MASI
About Masimo
Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.
In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.
Read More
- Five stocks we like better than Masimo
- 3 Stocks With Fresh Catalysts to Watch Before the July 4
- Amprius Insiders Are Selling: Should Investors Be Worried?
- A Weaker Dollar Could Put These 3 Industrial Stocks Back in Focus
- A Market Rotation Toward Quality Will Benefit These 3 ETFs
Want to see what other hedge funds are holding MASI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Masimo Corporation (NASDAQ:MASI – Free Report).
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.
